Biostar Pharmaceuticals, Inc., through its subsidiary, Shaanxi Biostar Biotech, Ltd., discovers, develops, manufactures, and markets over-the-counter and prescription pharmaceutical products, and nutrient products for various diseases and conditions in the People's Republic of China. Its primary product is Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B. The company's products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company holds licenses to produce and sell 13 nutrient products. Biostar Pharmaceuticals sells its products to pharmacies directly, as well as through a network of 20 distributors. It has research and development agreements with Fourth Military Medical University Xijing Hospital State Drug Clinical Research Center to conduct clinical trial for new drugs. The company was founded in 1995 and is headquartered in Xianyang City, the People's Republic of China.